Drug information update. Lithium and chronic kidney disease: Debates and dilemmas
Keyword(s):
The Past
◽
SummaryLithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the existence and magnitude of the risk. This article discusses the current evidence base regarding the link between lithium and chronic kidney disease, monitoring of renal functions and its clinical implications.
2014 ◽
Vol 12
(5S)
◽
pp. 789-792
2017 ◽
Vol 29
(3)
◽
pp. 243-255
◽
2019 ◽
Vol 14
(1)
◽
pp. 26-30
◽
2013 ◽
Vol 13
(3)
◽
pp. 88-90
◽
2017 ◽
Vol 7
(Suppl 1)
◽
pp. A9.3-A10
2014 ◽
Vol 204
(3)
◽
pp. 180-187
◽